References
- Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991; 253: 49–53.
- Kessis TD, Slebos RJ, Nelson WG, Kastan, MB, Plunkett BS, Han SM, Lorincz AT, Hedrick L, Cho KR. Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. Proc Natl Acad Sci USA 1993; 90: 3988–92.
- Fan S, Smith ML, Rivet DJ, Duba D, Zhan Q, Kohn KW, Fornace AJ Jr, O'Connor PM. Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pent-oxifylline. Cancer Res 1995; 55: 1649–54.
- Hawkins DS, Demers GW, Galloway DA. Inactivation of p53 enhances sensitivity to multiple chemotherapeutb agents. Cancer Res 1996; 56: 892–8.
- van Bree C, Rietbroek RC, Schopman EM, Kipp JB, Bakker PJ. Local hyperthermia enhances the effect of cis-diamminedichloro-platinun(H) on nonirradiated and preirra-diated rat solid tumors. Int J Radiat Oncol Biol Phys 1996; 36: 135–40.
- Rietbroek RC, Schilthuis MS, Bakker PJ, van Dijk JD, Postma AJ, Gonzalez Gonzalez D, Bakker AT, van der Velden J, Helmerhorst TJ, Veenhof CH. Phase II trial of weekly locoregional hyperthermia and cisplatin in patients with a previously irradiated recurrent carcinoma of the uterine cervix. Cancer 1997; 79: 935–43.
- Dahl O. Mechanisms of thermal enhancement of chemotherapeutic cytotoxicity. In: Urano M, Douple E, eds. Hypertherrrtia and Oncology. Utrecht VSP, 1994: 9–28.
- Nitta M, Okamura H, Aizawa S, Yamaizumi M. Heat shock induces transient p53-dependent cell cycle arrest at Gl/S. Oncogene 1997; 15: 561–8.
- Graeber TG, Peterson JF, Tsai M, Monica K, Fornace AJ Jr, Giaccia AT. Hypoxia induces accumulation of p53 protein, but activation of a Gl-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol Cell Biol 1994; 14: 6264–77.
- Matsumoto H, Hayashi S, Shioura H, Ohtsubo T, Kitai R, Ohnishi K, Hayashi N, Ohnishi T, Kano E. Suppression of heat-induced HSF activation by CDDP in human glioblastoma cells. Int J Radiat Oncol Biol Phys 1998; 41: 915–20.
- Kuerbitz SJ, Plunkett BS, Walsh WV, Kastan MB. Wild-type p53 is a cell cycle check-point determinant following irradiation. Proc Natl Acad Sci USA 1992; 89: 7491–5.
- van Bree C, Savonije JH, Franken NA, Haveman J, Bakker PJ. The effect of p53-function on the sensitivity to paclitaxel with or without hyperthermia in human colorectal carci-noma cells. Int J Oncol 2000; 16: 739–44.
- Dittmer D, Pati S, Zambetti G, Chu S, Teresky AK, Moore M, Finlay C, Levine AJ. Gain of function mutations in p53. Nature Genetics 1993; 4: 42–6.
- Smith ML, Chen IT, Zhan Q, O'Connor PM, Fornace AJ Jr. Involvement of the p53 tumor suppressor in repair of uv-type DNA damage. Oncogene 1995; 10: 1053–9.
- Ceraline J, Deplanque G, Duclos B, Limacher JM, Hajri A, Noel F, Orvain C, Frebourg T, Klein-Soyer C, Bergerat JP. Inactivation of p53 in normal human cells increases G2/M arrest and sensitivity to DNA-damaging agents. Int J Cancer 1998; 75: 432–8.
- Zhan Q, Bae I, Kastan MB, Fornace AJ Jr. The p53-dependent gamma-ray response of GADD45. Cancer Res 1994; 54: 2755–60.
- Hall PA, McKee PH, Menage HD, Dover R, Lane DP. High levels of p53 protein in UV-irradiated normal human skin. Oncogene 1993; 8: 203–7.
- Smith ML, Chen IT, Zhan Q, Bae I, Chen CY, Gilmer TM, Kastan MB, O'Connor PM, Fornace AJ Jr. Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. Science 1994; 266: 1376–80.
- Reed E. Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy. Cancer Treat Rev 1998; 24: 331–44.
- van Bree C, van der Maat B, Ceha HM, Franken NAP, Haveman J, Bakker PJM. Inactivation of p53 and of pRb protects human colorectal carcinoma cells against hyper-thermia-induced cytotoxicity and apoptosis. J Cancer Res Clin Oncol 1999; 125: 549–55.
- Matsumoto H, Takahashi A, Wang X, Ohnishi K, Ohnishi T. Transfection of p53-knock-out mouse fibroblasts with wild-type p53 increases the thermosensitivity and stimulates apoptosis induced by heat stress. Int J Radiat Oncol Biol Phys 1997; 39: 197–203.
- Roti Roti J, Kampinga HH, Malyapa RS, Wright WD, van der Waal RP, Xu M. Nuclear matrix as a target for hyperthermic killing of cancer cells. Cell Stress Chaperones 1998; 3: 245–55.